Clinical Trial Update: Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

This update summarizes Phase 2 results for a combination of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED